The Use of Filgrastim in Patients with Hodgkin Lymphoma Receiving ABVD

Background: There is conflicting data about the increased risk of pulmonary toxicity when granulocyte-stimulating factor (G-CSF) is given in combination with bleomycin. No clear consensus for management of patients with Hodgkin lymphoma (HL) who require G-CSF support exists. Our objective was to eva...

Descripción completa

Detalles Bibliográficos
Autores principales: Binder, Adam F., Rai, Sonia, Steinberg, Amir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tehran University of Medical Sciences, Hematology-Oncology and Stem Cell Transplantation Research Center 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5767288/
https://www.ncbi.nlm.nih.gov/pubmed/29340124

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5767288/
https://www.ncbi.nlm.nih.gov/pubmed/29340124

Ejemplares similares